WASHINGTON – The first U.S. study of the effect on people of exposure to a hormone-disrupting chemical widely used in food packaging showed that levels the Food and Drug Administration deems “safe” can alter insulin response, a key marker for diabetes.
The groundbreaking study , published in the Journal of the Endocrine Society, administered low doses of bisphenol A, or BPA, to 16 people, then tested their insulin production in response to glucose, commonly called blood sugar.
When insulin and blood glucose levels were compared to the same measurements taken without exposure to BPA, researchers found that BPA significantly changed how glucose affected insulin levels. Similar insulin and glucose tests are used by doctors for diagnosing diabetes.
“We’re living in an age where type 2 diabetes is rampant. Here is a signal of a new path to explore for what is causing it,” Pete Myers, a co-author of the study, told Environmental Health News. 
“These troubling findings should raise alarms at the Food and Drug Administration and ignite renewed efforts to drastically reduce all Americans’ exposure to BPA,” said Alexis Temkin, Ph.D., an EWG toxicologist.
“It’s appalling that the FDA and other federal agencies continue to say current exposure levels to BPA are safe, and refuse to ban BPA from food and food packaging.”
Independent research consistently documents serious health problems associated with low-dose exposure to BPA, yet the FDA continues to insist that the chemical is “safe at the current levels occurring in foods.” 
Read the full article at the Environmental Working Group .